The present study deals with the formulation and evaluation of transdermal patches of Glibenclamide towards enhance its permeation through the skin and maintain the plasma level concentration. Transdermal patches were prepared by using polymers like Chitosan, HPMC 15cps and EC 20cpsat various concentrations by solvent casting technique employing dibutyl phthalate as plasticizer and iso-propylmyristate as permeation enhancer. The transdermal patches were evaluated for their physico-chemical properties and in-vitro drug release. The transdermal patches were found to be transparent and smooth in texture. Among the formulations studied, at the end of 12 th hour, the minimum and maximum in-vitro drug release was observed for the formulations F12 and F4 i.e. 80.012 ± 2.012 % and 98.365±3.012% respectively. The mechanism of drug release was found to be Non-Fickian diffusion controlled. FT-IR studies revealed the integrity of the drug in the formulations.
INTRODUCTION
Transdermal drug delivery system has been in existence for a long time. In the past, the most commonly applied systems were topically applied creams and ointments for dermatological disorders the occurrence of systemic side-effects with some of these formulations is indicative of absorption through the skin 1 . A number of drugs have been applied to the skin for systemic treatment. In a broad sense, the term transdermal delivery system includes all topically administered drug formulations intended to deliver the active ingredient into the general circulation 2 .
Transdermal therapeutic systems have been designed to provide controlled continuous delivery of drugs via the skin to the systemic circulation [3] [4] . Moreover, it over comes various side effects like painful delivery of the drugs and the first pass metabolism of the drug occurred by other means of drug delivery systems 5 .
Glibenclamide and other NSAIDs the mechanism of release was diffusion mediated. The developed transdermal patches increase the efficacy of Glibenclamide for the therapy of arthritis and other painful muscular conditions [6] [7] [8] . Conventional systems of medication which require multi dose therapy have numerous problems and most recently, there is an increasing recognition that the skin can serve as the port provide continuous transdermal drug infusion into the systemic circulation [9] [10] [11] [12] . Transdermal therapeutic systems are defined as self-contained, discrete dosage forms when applied to the intact skin deliver the drug through the skin at controlled rate to the systemic circulation [15] [16] [17] [18] [19] . So, in present study formulated, evaluated and in-vitro drug release studies of Glibenclamide.
MATERIAL AND METHODS
Glibenclamide hydrochloride was received as a gift samples from Cadila Pharmaceutical, Ahmedabad and
Preparation of Transdermal Patches
The transdermal patches of Glibenclamide were prepared using combination of three polymers i.e. (Chitosan, HPMC, EC) (Table 1) in a suitable solvent system by solvent casting technique. Calculated amount of Glibenclamide was dissolved in methanol and was dispersed in polymeric solution. Dibutyl phthalate is used as plasticizer (30% weight of polymer) and Isopropyl myristate served as permeation enhancer (5% weight of polymer) were added and stirred to form uniform mixture. The resultant mixture was poured into petri dish having glass bangle (diameter 4.5 cm) lined with aluminum foil as a backing membrane. The prepared patches were allowed to dry at room temperature for 24 hrs. For complete drying, the moulds were kept in a hot air oven maintained at 45 ± 1ºC for another 4 hours. After complete drying, the patches were removed and stored in desiccators until used. The patches were smooth, flexible and could be cut to any desired size and shape [20] [21] [22] [23] [24] [25] [26] .
Evaluation of transdermal patches
The transdermal patches were evaluated for the following parameters.
Physical Appearance
All the prepared patches were visually inspected for color, clarity, flexibility and smoothness.
Thickness Uniformity
The thickness of the formulated film was measured at 3 different points using a mitutoya thickness gage 7301 made in Japan thickness of three reading was calculated. Average thickness was determined.
Folding Endurance
The folding endurance was determined to determine flexibility of film. The flexibility of the film is needed to handle the film easily and for comfortable, secured application of film on the wound. It was determined by repeatedly folding one film at same place till it breaks or folded up to 300 times manually. The number of times of film could be folded at the same place without breaking give the value of folding endurance.
Water Absorption Capacity
It is of utmost importance, if they are used for biological applications and wound healing. It is used to measure the capacity of film to absorb wound exudates. The initial weight of 1inch of dry film was noted. Then this film was placed in 15ml. of distilled water taken in Petri plate. The weight of the film was noted periodically at first hour, second hour, third hour and 24th hour. Every time after noting the weight, the film was placed in fresh water. Water absorption capacity of the film was calculated using a formula:
Percentage Moisture Loss
The films were weighed accurately and kept in a desiccators containing anhydrous calcium chloride. After 3 days, the films were taken out and weighed. The moisture loss was calculated using the formula:
Water Vapor Transmission Rate
Glass vials of 5 ml capacity were washed thoroughly and dried to a constant weight in an oven. About 1 g of fused calcium chloride was taken in the vials and the polymer films of2.25 cm2 were fixed over the brim with the help of an adhesive tape. Then the vials were weighed and stored in a humidity chamber of 80-90 % RH condition for a period of 24 h. The vials were removed and weighed at 24 h time intervals to note down the weight gain.
Transmission rate = -
Tensile strength
Tensile strength of the film was determined with Universal strength testing machine (JUSTY, Tensile Testing Machine, JTM 50 digital). The sensitivity of the machine was 1 g. It consisted of two load cell grips. The lower one was fixed and upper one was movable. The test film of size (10 × 10 mm 2 ) was fixed between these cell grips and force was gradually applied till the film broke. The tensile strength of the film was taken directly from the dial reading in kg. Tensile strength is expressed as follows:
Tensile Strength =
Drug content
An accurately cut patch of 1cm 2 area was taken and added to a beaker containing 1 ml phosphate buffer solution of pH 7.4 The beaker was kept 24 hours with occasion shaking. The sample was analyzed drug content using UV spectrophotometer 248nm.This study was performed for 3 times for a single patch.
In vitro Drug Release Studies
The in vitro evaluation was carried out in the modified Franz diffusion cell. This consists of an upper donor compartment and the lower receptor compartment, surrounded by water jacket for circulation of water to maintain the temperature inside at 32±1 0 C.The uniformity of solution in the receptor phase was maintained by stirring at high speed of 100 rpm (approximately) using a tiny magnetic bead the volume of receptor compartment was maintained at 60 ml and the diffusion surface are of 0.785 cm 2 . The receptor compartment was provided with the sampling port on one side, to withdraw sample at the predetermined time intervals for estimation of drug content by UV spectrophotometer.
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Experimental conditions
The receptor medium was phosphate buffer solution of pH 7.4, temperature of the receptor medium was maintained at 37 ± 2 0 C throughout the experiment using water jacket. The donor compartment was in contact with ambient condition of atmosphere.
RESULT AND DISCUSSION
In the present study, glibenclamide transdermal patches were prepared by solvent casting method. Polymers used for this study Chitosan, HPMC, EC employing aluminum foil as the backing membrane, Dibutyl phthalate used as plasticizer and Isopropyl myristate as permeation enhancer.
Thickness
The transdermal patches were transparent, smooth, uniform and flexible. Thicknesses of transdermal patches were found to be in the range of 0.02266 ± 0.0015 mm to 0.03533 ± 0.0025 mm ( Table 2 ). The low standard deviation values in the film thickness ensure uniformity of the patches prepared by solvent casting technique. The weights of formulations were found to be in the range of 0.1130 ± 0.0040 gm to 0.1736 ± 0.0015 gm. This indicated that there is no significant weight variation in all formulations and are as shown in Table  2 . 
Folding Endurance
In order to evaluate the flexibility, the films were subjected to folding endurance studies. The values in the range of 138 to 176 were observed in all batches. This revealed that the prepared films were having capability to withstand the mechanical pressure along with good flexibility. The formulation F6 was found to have lowest folding endurance, whereas formulation F4 was found to have highest folding endurance. The folding endurance results were shown in Table 2 .
Percentage Moisture Uptake and Loss
Among the formulations, F1 showed maximum moisture uptake i.e. 3.4533 ± 0.2318 % and F4 showed minimum moisture uptake i.e. 1.3433 ± 0.1457%. The percentage moisture uptake results are as shown in Table 2 . Among the formulations, F10 showed maximum moisture loss
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i.e. 4.3300 ± 0.0360 % and F1 showed minimum moisture loss i.e. 1.5150 ± 0.2700%. The percentage moisture loss results are as shown in Table 2 .
Tensile strength
The tensile strength was determined by using tensile strength tester (Test techno consultant, Vadodara) having the capacity of 10 kg. The results are as shown in Table 2 . It was found that the formulation F4 and F1 shown maximum (0.6130 ± 0.0010 kg/cm2) and minimum (0.3250 ± 0.0036 kg/cm2) tensile strength respectively among all the formulations.
Bursting strength
The bursting strength was determined by using bursting strength tester (Test Techno Consultant, Vadodara) having the capacity of 10 kg. From results are as shown in Table 2 , it is found that the formulation F4 and F8 shown maximum (2.9 kg/cm2) and minimum (2.2 kg/cm2) bursting strength respectively among all the formulations.
Drug content uniformity
The drug content uniformity of all the formulations was determined. The results of the drug content in all the formulations were found to be in the range of 96.5833 ± 1.5593 % to 98.4366 ± 0.9281 % and are as shown in Table 2 .
In-vitro drug release
The results of the (Figure 1 ) To ascertain the drug release mechanism, the formulations were plotted for Higuchi diffusion plots (Figure 2 ) by taking cumulative percent drug release versus square root of time. The plots were found to be fairly linear and the regression coefficient values were nearer to 1 in all the cases. So it confirmed that the drug release mechanism was diffusion mechanism. The formulations were also treated to Peppa's plot by taking log percent release versus log time ( Figure 3 ). The plots are found to be fairly linear and the regression values are nearer to 1. The values of slope of peppa's suggest that thedrug was released by Non-Fickian diffusion control (Anomalous diffusion) without any swelling. 
